| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-13 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |